Skip to main content
. 2013 Aug 1;8(8):e71094. doi: 10.1371/journal.pone.0071094

Table 1. Patient details.

Name Sex Pathology AO (yrs) Site(s) Microarray/PCR
D1, TJ MN STHS 7.7 shoulder Y/Y
D3, UH FN STHS 8 shoulder Y/Y
D4, BS MN STHS 6.5 elbow Y/Y
D5, BaS M STHS 7.6 knee Y/Y
D6, TV MN STHS 8.1 elbow Y/Y
D7, DV MN STHS 11 shoulder Y/Y
DX, YM MN STHS 9.7 shoulder N/Y
D2, BE M VHS 9.4 liver/spleen/lnn abd Y/Y
D8, DW M VHS 9.5 spleen/lnn abd Y/N
D9, JV FN VHS 8.9 lung/lnn mediast Y/Y
D11, BT F VHS 8.5 lung Y/Y
D12, AG M VHS 7.3 lung/spleen/kidney Y/Y
D13, TR FN VHS 7.9 lung Y/Y
D14, SG F VHS 4.1 lung/lnn mediast Y/Y
DX, SC MG VHS 10 liver/spleen N/Y

AO: Age of onset, M: male, MN: male neutered, F: female, FN: female neutered, STHS: soft tissue (localized) histiocytic sarcoma, VHS: visceral (disseminated) histiocytic sarcoma, lnn abd: abdominal lymphnodes, lnn mediast: mediastinal lymph nodes Note: For cases with VHS the site sampled for gene expressionis indicated in bold letters.